Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease

NCT07854808 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT07854808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07854808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease
Lead sponsor
The University of Queensland
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2027
Completion date
August 1, 2030
Enrollment
1,390 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, chronic illness, implementation research, kidney disease